Literature DB >> 6464117

A diagnostic "patch test" for onchocerciasis using topical diethylcarbamazine.

P Stingl, M Ross, D W Gibson, J Ribas, D H Connor.   

Abstract

There is great need for a simple, inexpensive, and sensitive diagnostic test for onchocerciasis, especially in endemic areas where trained personnel and laboratory facilities are limited. Diethylcarbamazine (DEC) was applied as a "patch test" to the skin of 45 patients with onchocerciasis in the Southern Sudan. 75 tests were done on these 45 patients, and 69 (92%) were positive. A positive reaction was a papular eruption beneath the patch. Histopathological studies of the skin beneath the patch revealed the microscopic features of a severe Mazzotti reaction, including degenerating microfilariae in the upper dermis and within epidermal eosinophilic abscesses.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6464117     DOI: 10.1016/0035-9203(84)90291-8

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

Review 1.  Treatment of onchocerciasis.

Authors:  Y Van Laethem; C Lopes
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

2.  [Onchocerciasis].

Authors:  C D Enk; K Gardlo; T Ruzicka; D BenEzra
Journal:  Hautarzt       Date:  2003-04-18       Impact factor: 0.751

3.  Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.

Authors:  K Awadzi; Nicholas O Opoku; Simon K Attah; Janis K Lazdins-Helds; Annette C Kuesel
Journal:  Parasit Vectors       Date:  2015-10-09       Impact factor: 3.876

4.  Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.

Authors:  Christian Bottomley; Valerie Isham; Sarai Vivas-Martínez; Annette C Kuesel; Simon K Attah; Nicholas O Opoku; Sara Lustigman; Martin Walker; Maria-Gloria Basáñez
Journal:  Parasit Vectors       Date:  2016-06-14       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.